[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.145.218.90. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1996

Cytomegalovirus Retinitis and Viral ResistancePrevalence of Resistance at Diagnosis, 1994

Author Affiliations

From the Departments of Ophthalmology (Drs Jabs, Dunn, and Bressler), Oncology (Dr Enger), Pathology (Mr Forman and Dr Charache), and Medicine (Dr Jabs), The Johns Hopkins University School of Medicine, Baltimore, Md. Members of the Cytomegalovirus and Viral Resistance Study Group are listed in a box on page 811.

Arch Ophthalmol. 1996;114(7):809-814. doi:10.1001/archopht.1996.01100140023002
Abstract

Objective:  To determine the prevalence of cytomegalovirus (CMV) isolates resistant to ganciclovir sodium or foscarnet sodium at the time of diagnosis of CMV retinitis, prior to the initiation of therapy.

Design:  Prospective epidemiologic study. Setting: An acquired immunodeficiency syndrome ophthalmology clinic.

Patients:  Patients with acquired immunodeficiency syndrome and newly diagnosed CMV retinitis.

Intervention:  Culturing blood and urine samples for CMV and testing of all positive isolates for sensitivity to ganciclovir and foscarnet.

Main Outcome Measure:  Prevalence of the following: blood culture isolates resistant to ganciclovir (inhibitory concentration 50% [IC50]>5.5 μmol/L) or foscarnet (IC50>400 μmol/L) and urine culture isolates resistant to ganciclovir or foscarnet.

Results:  Forty-nine patients were enrolled during a 13-month period. Forty-four patients had blood culture samples that could be evaluated; of these, 66% were positive (59% of patients). Thirty-four patients had urine cultures that were evaluable; of these, 82% were positive (57% of patients). Overall, 78% of patients had either a urine or blood culture sample positive for CMV. No blood culture isolates were resistant to ganciclovir, and only 1 urine culture isolate (2% of patients) was resistant to ganciclovir. Three percent of blood culture isolates and 4% of urine culture isolates (2% and 2% of patients, respectively) were resistant to foscarnet. Overall, 4% of patients had either a blood or urine culture isolate resistant to foscarnet.

Conclusion:  Resistance to ganciclovir or foscarnet at the time of diagnosis of CMV retinitis is uncommon.

×